HKSH's first-in-Asia comparative study found hypofractionated proton therapy prevented breast cancer recurrence with a 100 per cent survival rate, minimising cardiopulmonary risks and maintaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results